Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pecans may lower cholesterol and curb heart disease risk

NCT ID NCT07696403

Not yet recruiting Disease control Sponsor: University of Georgia Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests whether eating a daily serving of pecans for 12 weeks can improve cholesterol levels and other markers of heart-disease risk. Adults aged 25–75 who are overweight or have borderline-high cholesterol will either add pecans to their diet or stick with their usual eating habits. Researchers will measure changes in blood fats, appetite hormones, and other health indicators to see if this simple dietary change makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pecans
What this could lead to
If it works, this could show that a simple dietary change — eating a handful of pecans daily — helps lower cholesterol and reduce heart-disease risk.
What could go wrong
This is a small, short-term study (90 people, 12 weeks). Results may not apply to everyone, and the effect might be too small to matter in real life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyslipidemias inherited lipid metabolism disorder Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DYSLIPIDEMIA NUTRITION, HEALTHY OVERWEIGHT AND OBESITY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Georgia

    Athens, Georgia, 30602, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.